mailed
on 05 Nov 2024
Last Applicant/ Owned by
Paasheuvelweg 25
Amsterdam
NL
1105BP
Serial Number
98371742 filed on 23rd Jan 2024
Registration Number
N/A
Correspondent Address
Erica R. Halstead
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medical and scientific research, product development and consultancy in the fields of biotechnology, biology, biopharmaceutical research and development, medical science, chemistry and biochemistry; Providing medical and scientific research information and advice in the fields of biotechnology, biology, biopharmaceutical research and development, medical science, chemistry and biochemistry Medica Read More
Medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders using gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation; Providing medical information and advice in the field of medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders using gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation
N/A
N/A
Medical and scientific research, product development and consultancy in the fields of biotechnology, biology, biopharmaceutical research and development, medical science, chemistry and biochemistry; Providing medical and scientific research information and advice in the fields of biotechnology, biology, biopharmaceutical research and development, medical science, chemistry and biochemistry
N/A
N/A
Viral systems, gene therapy systems, nucleic acid delivery systems, all comprised of biological preparations in the nature of viruses for medical purposes; viral vectors, gene therapy vectors, nucleic acid delivery vectors, all comprised of biological preparations in the nature of viruses for medical purposes; pharmaceutical products for the treatment of diseases; biological preparations for use in medical purposes, namely, in medical and clinical gene therapy, nucleic acid-based therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, gene diagnosis and gene testing; pharmaceutical preparations being prophylaxis products for use in nucleic acid-based therapy and gene therapy
N/A
N/A
Viral systems, gene therapy systems, and nucleic acid delivery systems, all comprised of biological preparations in the nature of viruses for use in cell cultures for non-medical, scientific research purposes; viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors all comprised of biological preparations in the nature of viruses for use in cell cultures for non-medical, scientific research purposes
N/A
N/A
No 98371742
No Service Mark
No 115710.01079
Yes
Yes
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
05th Nov 2024 | SUSPENSION LETTER WRITTEN |
05th Nov 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
05th Nov 2024 | LETTER OF SUSPENSION E-MAILED |
16th Oct 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
15th Oct 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
15th Oct 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
27th Aug 2024 | NON-FINAL ACTION WRITTEN |
27th Aug 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
27th Aug 2024 | NON-FINAL ACTION E-MAILED |
19th Aug 2024 | ASSIGNED TO EXAMINER |